Japanese companies from the pharmaceutical sector visit Pharmaloop’s facilities
Japanese companies from the pharmaceutical sector visit Pharmaloop’s facilities (a Salvat company) through @ICEX and @IcexJapon.
About Carme Lopez
This author has yet to write their bio.Meanwhile lets just say that we are proud Carme Lopez contributed a whooping 62 entries.
Entries by Carme Lopez
Salvat and Pharmaloop were present at the CPhI Worldwide 2019
19/11/2019 in Salvat International, Salvat Spain, Salvat USA /by Carme LopezOn the 5th, 6th and 7th of November, the city of Frankfurt hosted one of the largest events worldwide in the pharmaceutical industry, bringing together over 45,000 visiting attendees and 2,500 international exhibitors: CPhI Worldwide 2019. Salvat and Pharmaloop teams held numerous meetings with current and potential partners from all over the world of the […]
Salvat was present at The Bio International Convention 2019, at Philadelphia, US.
25/06/2019 in Salvat International, Salvat Spain, Salvat USA /by Carme LopezSalvat was present at the world’s largest pharmaceutical biotechnology event: The Bio International Convention 2019, which took place this year in Philadelphia (USA), from June 3rd to 6th, where meetings were held with companies from the pharmaceutical industry from all over the world. The aim was to explore new business opportunities for licensing our products and […]
Salvat and Pharmaloop participated in the CPhI Worldwide Congress
16/10/2018 in Salvat International, Salvat Spain, Salvat USA /by Carme LopezSalvat and Pharmaloop participated in the CPhI Worldwide Congress, which annually gathers the most important companies in the pharmaceutical world. This year it was held in Madrid, where both companies had the opportunity to hold many meetings with other pharmaceutical companies to explore opportunities that allow us to increase our activities internationally.
Laboratorios Salvat has participated in the consortium created for the development of the INDREYE research project “Innovative solutions for the treatment and diagnosis of dry eye syndrome”
11/10/2018 in Salvat Spain /by Carme LopezLaboratorios Salvat has participated in the consortium created for the development of the INDREYE research project “Innovative solutions for the treatment and diagnosis of dry eye syndrome” funded by the Spanish National Program of Public-Private Cooperation, subprogram INNPACTO, 2012 call. This program is co-financed by the European Union through the European regional development fund (ERDF/FEDER).
Laboratorios SALVAT maintains the rating of ‘VERY GOOD’ in the PROFARMA call in 2018
12/09/2018 in Salvat Spain /by Carme LopezOn July 26, 2018, the Spanish Ministry of Industry, Commerce and Tourism, through the General Secretariat of Industry and Small and Medium Enterprises resolved to grant Laboratorios Salvat its classification within Group A: Companies with significant research activity with own pharmaceutical production plant or its own basic or preclinical R & D center, with the […]
Laboratorios Salvat completes patient recruitment for the CIFLOTEX trial
12/09/2018 in Salvat International, Salvat USA /by Carme LopezOn August 30th 2018, the enrolment of patients into the CIFLOTEX clinical trial was completed. This study has been carried out in 45 US centers, and 493 patients suffering from Acute Otitis Externa (AOE) have been included. The objective of the study is to assess the efficacy and safety of our combination of Ciprofloxacin + […]
Laboratorios Salvat was represented at the 2018 BIO International Convention
13/06/2018 in Salvat International /by Carme LopezSalvat was part of the most important International Biotechnology congress, which was held at the Boston Convention Center (Massachusetts, USA) from July 4 to 7, 2018. BIO is a unique opportunity for companies in the pharmaceutical industry to establish relationships of scientific and commercial nature, as well as close deals and explore further collaborations with […]